Thrombin receptor-activating peptides (TRAPs): Investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies
Ma. Ceruso et al., Thrombin receptor-activating peptides (TRAPs): Investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies, BIO MED CH, 7(11), 1999, pp. 2353-2371
The thrombin receptor (PAR-1) is an unusual transmembrane G-protein coupled
receptor in that it is activated by serine protease cleavage of its extrac
ellular N-terminus to expose an agonist peptide ligand, which is tethered t
o the receptor itself. Synthetic peptides containing the agonist motif, suc
h as SFLLRN for human PAR-1, are capable of causing full receptor activatio
n. We have probed the possible bioactive conformations of thrombin receptor
-activating peptides (TRAPs) by systematic introduction of certain conforma
tional perturbations, involving alpha-methyl, ester Psi(COO), and reduced-a
mide Psi(CH2N) scans, into the minimum-essential agonist sequence (SFLLR) t
o probe the importance of the backbone conformation and amide NH hydrogen b
onding. We performed extensive conformational searches of representative pe
ntapeptides to derive families of putative bioactive structures. In additio
n, we employed H-1 NMR and circular dichroism (CD) to characterize the conf
ormational disposition of certain pentapeptide analogues experimentally. Ac
tivation of platelet aggregation by our pentapeptide analogues afforded a s
tructure-function correlation for PAR-1 agonist activity. This correlation
was assisted by PAR-1 receptor binding data, which gauged the affinity of p
eptide ligands for the thrombin receptor independent of a functional cellul
ar response derived from receptor activation (i.e. a pure molecular recogni
tion event). Series of alanine-, proline-, and N-methyl-scan peptides were
also evaluated for comparison. Along with the known structural features for
PAR-1 agonist peptides, our work adds to the understanding of peptide topo
graphy relative to platelet functional activity and PAR-1 binding. The abso
lute requirement of a positively charged N-terminus for strong agonist acti
vity was contradicted by the N-terminal hydroxyl peptide Psi(HO)S-FLLR-NH2.
The amide nitrogen between residues 1 and 2 was found to be a determinant
of receptor recognition and the carbonyl groups along the backbone may be i
nvolved in hydrogen bonding with the receptor. Position 3 (P3) of TRAP-5 is
known to tolerate a wide variety of side chains, but we also found that th
e amide nitrogen at this position can be substituted by an oxygen, as in SF
-Psi(COO)-LLR-NH2, without diminishing activity. However, this peptide bond
is sensitive to conformational changes in that SFPLR-NH2 was active, where
as SF-NMeL-LR-NH2 was not. Additionally, we found that position 3 does not
tolerate rigid spacers, such as 3-aminocyclohexane-1-carboxylic acid and 2-
aminocycloalkane-1-carboxylic acid, as analogues 1A, 1B, 2A, 2B, 3, 4, 5A a
nd 5B lack agonist activity. On the basis of our results, we suggest that a
n extended structure of the agonist peptide is principally responsible for
receptor recognition (i.e. binding) and that hydrophobic contact may occur
between the side chains of the second (Phe) and fourth (Leu) residues (i.e.
P2-P4 interaction). (C) 1999 Elsevier Science Ltd. All rights reserved.